US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 0.3121
- -0.0480-13.33%
Close Jun 18 16:00 ET
7.06MMarket Cap-156P/E (TTM)
0.3700High0.3100Low428.15KVolume0.3700Open0.3601Pre Close142.73KTurnover2.15%Turnover RatioLossP/E (Static)22.63MShares3.900052wk High-0.39P/B6.21MFloat Cap0.310052wk Low--Dividend TTM19.89MShs Float52.1950Historical High--Div YieldTTM16.66%Amplitude0.3100Historical Low0.3330Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Aslan Pharmaceuticals Stock Forum
ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company dedicated to developing innovative treatments for patients, has announced a significant late-breaking poster presentation at the American Thoracic Society (ATS) International Conference 2024 in San Diego, Californ...
•Late breaking poster presentation of positive translational data from a head-to-head study of eblasakimab versus dupilumab in a human tissue model of COPD at the American Thoracic Society International Conference 2024 on May 20, 2024 •Topline interim data from the farudodstat Phase 2a study in AA expected in Q3 2024•Topline data from the TREK-DX trial of eblasakimab expected at the end of 2024•Selection of a dev...
Hi @Trytosaveabit May i kindly get ur opinion/ analysis on this company (No advise on buy sell).
No comment yet